EDGAR Filing Documents for 0001193125-21-307325

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001193125-21-307325

Filing Date

2021-10-26

Accepted

2021-10-26 08:39:26

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	d241049d424b3.htm	424B3	1608338
2	GRAPHIC	g241049g13a30.jpg	GRAPHIC	128992
3	GRAPHIC	g241049g13a40.jpg	GRAPHIC	137639
4	GRAPHIC	g241049g13c77.jpg	GRAPHIC	134877
5	GRAPHIC	g241049g16i22.jpg	GRAPHIC	98342
6	GRAPHIC	g241049g17u63.jpg	GRAPHIC	149564
7	GRAPHIC	g241049g23p99.jpg	GRAPHIC	130055
8	GRAPHIC	g241049g28w56.jpg	GRAPHIC	68283
9	GRAPHIC	g241049g44i44.jpg	GRAPHIC	70932
10	GRAPHIC	g241049g67w31.jpg	GRAPHIC	95674
11	GRAPHIC	g241049g74p07.jpg	GRAPHIC	133689
12	GRAPHIC	g241049g81v00.jpg	GRAPHIC	109571
	Complete submission text file	0001193125-21-307325.txt		3303867

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306

Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676

Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-260246 | Film No.: 211346073
SIC: 2834 Pharmaceutical Preparations